Interventional Neuroradiology - Market Insights, Competitive Landscape, and Market Forecast - 2032

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of neurological disorders such as cerebral aneurysms and growing technical advancements in the domain of interventional neuroradiology

The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032. The demand for interventional neuroradiology is primarily driven by the rising incidence of neurological disorders, particularly cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs). The growing prevalence of these conditions has heightened the need for minimally invasive diagnostic and therapeutic procedures to improve patient outcomes and reduce recovery times.

Additionally, advancements in technology are playing a pivotal role in propelling market growth during the forecast period (2025 to 2032). Innovations such as the development of next-generation flow diversion devices, highly flexible microcatheters, enhanced imaging technologies, and robot-assisted interventions have significantly improved the precision, safety, and efficacy of interventional neuroradiology procedures. These advancements have enabled the treatment of complex neurological conditions that were previously considered inoperable or carried higher surgical risks.

Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging is enhancing early detection and treatment planning, thereby driving the adoption of interventional neuroradiology solutions. The increasing preference for minimally invasive procedures, combined with rising patient awareness and improved healthcare infrastructure, is further accelerating market expansion across various regions.

Interventional Neuroradiology Market Dynamics:

The interventional neuroradiology market is projected to experience significant growth during the forecast period, driven by the rising prevalence of neurological disorders, increasing incidence of strokes, and ongoing technological advancements in treatment devices.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the United States have an unruptured brain aneurysm, with around 30,000 cases of aneurysm rupture reported annually. Brain aneurysm ruptures can lead to life-threatening conditions such as subarachnoid hemorrhage and require urgent interventional procedures like endovascular coiling or the use of flow diverters. The increasing prevalence of brain aneurysms has resulted in heightened awareness, improved diagnostic capabilities, and a corresponding rise in demand for advanced interventional neuroradiology (INR) devices. Early detection and treatment significantly reduce mortality and improve long-term outcomes, further propelling market growth.

Stroke prevalence is another critical factor fueling market demand. According to the Global Stroke Fact Sheet (2022), there were approximately 12.22 million incident stroke cases globally in 2022, with over 7.6 million ischemic strokes accounting for 62% of all strokes. Ischemic strokes occur due to blocked arteries, and interventional neuroradiology techniques such as mechanical thrombectomy and stent retrievers are essential in restoring blood flow and reducing the risk of long-term disability. Timely interventions significantly improve patient recovery and survival rates, which has boosted the adoption of INR procedures across emergency care settings.

Technological innovations in the interventional neuroradiology field further support market expansion. Advancements include the development of next-generation stents and flow diverters with improved flexibility, durability, and biocompatibility, which enhance performance and reduce complications such as in-stent thrombosis or device migration. Moreover, innovations in microcatheter and microguidewire technologies have improved precision and navigability through the brain’s complex vascular network, allowing for safer and more effective treatment of complex aneurysms and arteriovenous malformations (AVMs). Cutting-edge technologies like robot-assisted interventions and real-time imaging advancements are also enabling minimally invasive procedures with shorter recovery times and reduced risks, which are becoming increasingly preferred by both patients and healthcare providers.

Despite these positive drivers, the market faces challenges such as complications associated with interventional devices (e.g., vessel perforation, device migration, or thromboembolic events) and the stringent regulatory landscape for device approval. Regulatory authorities require extensive clinical data to ensure safety and efficacy, which can delay product launches and increase development costs.

Nevertheless, the rising global burden of neurological and cerebrovascular diseases, increasing awareness of early intervention benefits, and continuous technological progress are expected to outweigh the challenges, thereby propelling the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

Interventional Neuroradiology Market Segment Analysis:

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the interventional neuroradiology market, the flow diversion stents category is projected to amass a significant revenue share in 2024, driven by their versatile applications, clinical advantages, and increasing product approvals that are collectively fueling market demand during the forecast period.

Flow diversion stents have emerged as a preferred treatment option for managing complex intracranial aneurysms, particularly those that are large, wide-necked, or fusiform cases that are challenging to treat with traditional methods such as endovascular coiling. These stents work by redirecting blood flow away from the aneurysm sac, promoting endothelial growth along the stent, and ultimately sealing off the aneurysm over time. Flow diversion therapy is especially beneficial for aneurysms that have recurred after previous treatments, offering a reliable alternative with long-term durability and lower recurrence rates.

One of the key benefits of flow diversion stents is their minimally invasive nature. The procedure is typically performed using a catheter-based delivery system through the femoral or radial artery, reducing the risks associated with open craniotomy and shortening recovery times. Unlike traditional coiling, direct manipulation of the aneurysm sac is avoided, significantly reducing the risk of rupture during the procedure. Moreover, many flow diversion techniques do not require adjunctive devices like coils or balloons, simplifying the intervention process and minimizing device-related complications.

The market growth for flow diversion stents is further fueled by a surge in product approvals and technological advancements. For instance, in December 2023, MicroPort® NeuroTech™ received approval from the Brazilian National Health Surveillance Agency (ANVISA) for its Tubridge® Vascular Reconstruction Device. The Tubridge® is a dense-mesh stent applying flow diversion therapy principles, designed specifically to treat large or giant wide-necked intracranial aneurysms. Such innovations offer improved device flexibility, better wall apposition, and enhanced navigability through tortuous cerebral vessels, making them suitable for treating complex cases with greater precision and safety.

Additionally, the rising prevalence of intracranial aneurysms, increased awareness of early diagnosis, and growing demand for minimally invasive interventions are key contributors to the expanding market share of flow diversion stents. As more healthcare facilities adopt these advanced devices and as clinical guidelines increasingly support their use for various aneurysm types, the adoption rate is expected to rise globally.

Therefore, owing to the aforementioned factors including their clinical efficacy, safety profile, technological advancements, and regulatory approvals the flow diversion stents category is poised to register significant growth, thereby driving the overall expansion of the interventional neuroradiology market during the forecast period (2025 to 2032).

North America is expected to dominate the overall interventional neuroradiology market:

North America is anticipated to account for the largest share of the interventional neuroradiology market in 2024, driven by a large patient pool affected by ischemic strokes, transient ischemic attacks (TIA), and a growing geriatric population. Additional factors such as advanced healthcare infrastructure, technological innovations, and robust product development pipelines are further propelling market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) 2023, approximately 795,000 people in the United States experience a stroke each year, with 87% being ischemic strokes caused by a blockage of blood flow to the brain. The high prevalence of ischemic strokes, coupled with the need for rapid intervention to improve patient outcomes, has increased the demand for interventional neuroradiology devices, including mechanical thrombectomy devices, stent retrievers, and aspiration catheters.

The aging population in North America further contributes to the rising incidence of strokes and TIAs. According to the US Census Bureau 2021 report, over 54 million adults aged 65 and older were living in the United States in 2021. This demographic is expected to rise to approximately 85.7 million by 2050, representing nearly 20% of the overall US population. The elderly population, particularly those above 50 years, are at a higher risk of ischemic strokes and TIA due to age-related vascular changes such as arterial narrowing, arteriosclerosis, and atherosclerosis. This underscores the growing need for minimally invasive treatments to manage these conditions effectively.

Additionally, the high adoption rate of innovative technologies and the presence of major market players in the region foster continuous product launches and regulatory approvals. For example, the United States Food and Drug Administration (FDA) has expedited the approval of various neurovascular devices to enhance stroke care. The region’s robust research and development activities, favorable reimbursement policies, and widespread use of advanced imaging technologies further support early diagnosis and prompt intervention, contributing to market expansion.

The strategic collaborations between healthcare providers, academic institutions, and medical device manufacturers in North America also play a crucial role in accelerating product innovations and expanding treatment accessibility. Moreover, the increasing awareness of stroke symptoms and improved emergency medical services are enabling faster treatment initiation, which is critical in ischemic stroke management.

Therefore, the combination of a growing stroke patient population, an aging demographic, technological advancements, and a supportive regulatory environment positions North America as the leading region in the interventional neuroradiology market during the forecast period (2025 to 2032).

Interventional Neuroradiology Market Key Players:

Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

Recent Developmental Activities in the Interventional Neuroradiology Market:

In October 2023, the Royal Australian and New Zealand College of Radiologists (RANZCR) launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology during its 72nd Annual Scientific Meeting (ASM) held in Adelaide. These standards aim to enhance patient safety, optimize clinical outcomes, and ensure consistent quality of care in interventional radiology and neuroradiology procedures across the region.

In June 2022, Stryker announced a partnership with Carmeda to develop an advanced flow diverter featuring active drug coating technology. This collaboration aims to enhance aneurysm treatment by improving device biocompatibility and reducing the risk of thrombosis, ultimately offering better long-term patient outcomes in the management of complex cerebral aneurysms.

Key Takeaways from the Interventional Neuroradiology Market Report Study

Market size analysis for current interventional neuroradiology market size (2024), and market forecast for 8 years (2025 to 2032)

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.

Key companies dominating the interventional neuroradiology market.

Various opportunities available for the other competitors in the interventional neuroradiology market space.

What are the top-performing segments in 2024? How these segments will perform in 2032?

Which are the top-performing regions and countries in the current interventional neuroradiology market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for interventional neuroradiology market growth in the coming future?

Target Audience Who Can be Benefited from this Interventional Neuroradiology Market Report Study

Interventional neuroradiology product providers

Research organizations and consulting companies

Interventional Neuroradiology related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in the interventional neuroradiology market

Various end-users who want to know more about the interventional neuroradiology market and the latest technological developments in the interventional neuroradiology market.

Frequently Asked Questions for the Interventional Neuroradiology Market:

1. What is meant by interventional neuroradiology?

Interventional Neuroradiology is a subspecialty of radiology that focuses on diagnosing and treating disorders of the central nervous system (CNS), including the brain, spine, head, and neck. It combines expertise in neuroanatomy, imaging techniques, and endovascular (within the blood vessels) methods.

2. What is the market for interventional neuroradiology?

The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032.

3. What are the drivers for the global interventional neuroradiology market?

The interventional neuroradiology market is primarily being boosted by the rising incidence of neurological disorders such as cerebral aneurysms. Additionally, increasing technological advancements in the domain of interventional neuroradiology is another key factor, which is responsible for contributing to the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global interventional neuroradiology market?

Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

5. Which region has the highest share in the global interventional neuroradiology market?

North America is expected to dominate the overall interventional neuroradiology market during the forecast period, 2025 to 2032. This is due to the presence of a large patient pool suffering from ischemic stroke, and transient ischemic attack (TIA). Additionally, the rising geriatric population, the presence of developed and sophisticated healthcare infrastructure, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the interventional neuroradiology market in North America.